- Home
- NVCR vs CENTA Comparison
NVCR vs CENTA Comparison
Compare NVCR & CENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- CENTA
- Stock Information
- Founded
- NVCR 2000
- CENTA 1955
- Country
- NVCR Switzerland
- CENTA United States
- Employees
- NVCR N/A
- CENTA N/A
- Industry
- NVCR Medical/Dental Instruments
- CENTA Consumer Specialties
- Sector
- NVCR Health Care
- CENTA Consumer Discretionary
- Exchange
- NVCR Nasdaq
- CENTA Nasdaq
- Market Cap
- NVCR 2.3B
- CENTA 2.0B
- IPO Year
- NVCR 2015
- CENTA 1993
- Fundamental
- Price
- NVCR $22.09
- CENTA $32.05
- Analyst Decision
- NVCR Buy
- CENTA Strong Buy
- Analyst Count
- NVCR 5
- CENTA 5
- Target Price
- NVCR $33.40
- CENTA $41.50
- AVG Volume (30 Days)
- NVCR 741.8K
- CENTA 257.8K
- Earning Date
- NVCR 02-27-2025
- CENTA 02-05-2025
- Dividend Yield
- NVCR N/A
- CENTA N/A
- EPS Growth
- NVCR N/A
- CENTA N/A
- EPS
- NVCR N/A
- CENTA 1.82
- Revenue
- NVCR $577,738,000.00
- CENTA $3,222,363,000.00
- Revenue This Year
- NVCR $19.97
- CENTA $2.92
- Revenue Next Year
- NVCR $2.83
- CENTA $2.16
- P/E Ratio
- NVCR N/A
- CENTA $17.79
- Revenue Growth
- NVCR 14.63
- CENTA N/A
- 52 Week Low
- NVCR $11.70
- CENTA $27.70
- 52 Week High
- NVCR $34.13
- CENTA $41.03
- Technical
- Relative Strength Index (RSI)
- NVCR 36.77
- CENTA 48.08
- Support Level
- NVCR $21.38
- CENTA $32.17
- Resistance Level
- NVCR $22.95
- CENTA $34.14
- Average True Range (ATR)
- NVCR 0.86
- CENTA 0.97
- MACD
- NVCR 0.01
- CENTA -0.02
- Stochastic Oscillator
- NVCR 34.25
- CENTA 33.19
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About CENTA Central Garden & Pet Company Nonvoting
Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.